Publication	Data		Fish	Anatomy
Ciapaite et al., 2025	Figure 1		alplzf4270/+ (TL) ,   alplzf4270/zf4270 (TL)	whole organism alpl expression absent, abnormal whole organism alpl expression decreased amount, abnormal whole organism alkaline phosphatase activity decreased magnitude, abnormal
	Figure 2		alplzf4270/zf4270 (TL)	vitamin B6 metabolic process process quality, abnormal whole organism 4-pyridoxic acid decreased amount, abnormal whole organism bone mineralization decreased occurrence, abnormal whole organism pyridoxal 5'-phosphate decreased amount, abnormal whole organism pyridoxal decreased amount, abnormal
	Figure 3		alplzf4270/zf4270 (TL)	locomotory behavior process quality, abnormal
	Figure 4		alplzf4270/zf4270 (TL)	locomotory behavior process quality, abnormal vitamin B6 metabolic process process quality, abnormal whole organism asparagine decreased amount, abnormal whole organism gamma-aminobutyric acid decreased amount, abnormal whole organism glutamine decreased amount, abnormal whole organism methionine increased amount, abnormal
	Figure 6		alplzf4270/zf4270 (TL)	phenylalanine decarboxylase activity process quality, abnormal polyamine biosynthetic process process quality, abnormal whole organism (R)-adrenaline decreased amount, abnormal whole organism 2-[3-carboxy-3-(methylammonio)propyl]-L-histidine decreased amount, abnormal whole organism decreased life span, abnormal whole organism decreased mobility, abnormal whole organism gamma-aminobutyric acid decreased amount, abnormal whole organism L-dopa increased amount, abnormal whole organism N-methylethanolaminium phosphate(1-) increased amount, abnormal whole organism retinal decreased amount, abnormal whole organism retinol increased amount, abnormal whole organism Vanillactic acid increased amount, abnormal
Hark et al., 2025	Fig. 2		alplwue7/wue7 (AB)	neurocranium bone mineralization disrupted, abnormal neurocranium morphology, abnormal splanchnocranium bone mineralization disrupted, abnormal splanchnocranium morphology, abnormal